Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Sattler

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2016
MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung CancerMartin Sattler, Ravi Salgia
Haematologica|November 6, 2012
A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3Ellen Weisberg, Martin Sattler
Cancers|May 13, 2026
Diagnostic Challenges in Pleural MesotheliomaMoshe Lapidot, Martin Sattler
Cell Reports. Medicine|February 28, 2025
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancerMartin Sattler, Ravi Salgia
Seminars in Hematology|June 5, 2003
Molecular mechanisms of transformation by the BCR-ABL oncogeneMartin Sattler, James D Griffin
Journal of the National Cancer Institute|May 2, 2007
Chronic myelogenous leukemia progenitors display a genetically unstable personalityMargret S Rodrigues, Martin Sattler
Cancer Cell|November 3, 2009
JAK2 gets histone H3 rollingMartin Sattler, James D Griffin
Methods in Molecular Medicine|April 25, 2003
Cell motility, adhesion, homing, and migration assays in the studies of tyrosine kinasesMartin Sattler, Elizabeth Quackenbush, Ravi Salgia
Thescientificworldjournal|October 7, 2008
EGFR-targeted therapeutics: focus on SCCHN and NSCLCMartin Sattler, Oyewale Abidoye, Ravi Salgia
Cancer Treatment and Research|May 29, 2004
Therapeutic targeting of the receptor tyrosine kinase MetMartin Sattler, Patrick C Ma, Ravi Salgia
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 28, 2016
MET in the Driver's Seat: Exon 14 Skipping Mutations as Actionable Targets in Lung CancerMartin Sattler, Ravi Salgia
Haematologica|November 6, 2012
A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3Ellen Weisberg, Martin Sattler
Cancers|May 13, 2026
Diagnostic Challenges in Pleural MesotheliomaMoshe Lapidot, Martin Sattler
Cell Reports. Medicine|February 28, 2025
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancerMartin Sattler, Ravi Salgia
Seminars in Hematology|June 5, 2003
Molecular mechanisms of transformation by the BCR-ABL oncogeneMartin Sattler, James D Griffin
Journal of the National Cancer Institute|May 2, 2007
Chronic myelogenous leukemia progenitors display a genetically unstable personalityMargret S Rodrigues, Martin Sattler
Cancer Cell|November 3, 2009
JAK2 gets histone H3 rollingMartin Sattler, James D Griffin
Methods in Molecular Medicine|April 25, 2003
Cell motility, adhesion, homing, and migration assays in the studies of tyrosine kinasesMartin Sattler, Elizabeth Quackenbush, Ravi Salgia
Thescientificworldjournal|October 7, 2008
EGFR-targeted therapeutics: focus on SCCHN and NSCLCMartin Sattler, Oyewale Abidoye, Ravi Salgia
Cancer Treatment and Research|May 29, 2004
Therapeutic targeting of the receptor tyrosine kinase MetMartin Sattler, Patrick C Ma, Ravi Salgia
Pageof 13